These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15726103)
1. Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Moss S; Waller M; Anderson TJ; Cuckle H; Br J Cancer; 2005 Mar; 92(5):955-60. PubMed ID: 15726103 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892 [TBL] [Abstract][Full Text] [Related]
3. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. Moss S J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845 [TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Moss S; Thomas I; Evans A; Thomas B; Johns L; Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102 [TBL] [Abstract][Full Text] [Related]
5. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099 [TBL] [Abstract][Full Text] [Related]
6. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144 [TBL] [Abstract][Full Text] [Related]
8. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. FH01 collaborative teams Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374 [TBL] [Abstract][Full Text] [Related]
9. Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Huang H; Ergun MA; Burnside ES; Xu C; Li Y; Alagoz O; Lee SJ; Stout NK; Song J; Trentham-Dietz A; Plevritis SK; Moss SM; de Koning HJ Med Decis Making; 2018 Apr; 38(1_suppl):140S-150S. PubMed ID: 29554468 [TBL] [Abstract][Full Text] [Related]
10. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L; Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727 [TBL] [Abstract][Full Text] [Related]
11. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research. Breast Screening Frequency Trial Group Eur J Cancer; 2002 Jul; 38(11):1458-64. PubMed ID: 12110490 [TBL] [Abstract][Full Text] [Related]
12. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331 [TBL] [Abstract][Full Text] [Related]
13. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial. Frisell J; Lidbrink E; Hellström L; Rutqvist LE Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870 [TBL] [Abstract][Full Text] [Related]
14. Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits. Berrington de González A; Reeves G Br J Cancer; 2005 Sep; 93(5):590-6. PubMed ID: 16136033 [TBL] [Abstract][Full Text] [Related]
15. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
16. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. Jonsson H; Nyström L; Törnberg S; Lenner P J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556 [TBL] [Abstract][Full Text] [Related]
17. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005 [TBL] [Abstract][Full Text] [Related]
18. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. Mittra I; Mishra GA; Dikshit RP; Gupta S; Kulkarni VY; Shaikh HKA; Shastri SS; Hawaldar R; Gupta S; Pramesh CS; Badwe RA BMJ; 2021 Feb; 372():n256. PubMed ID: 33627312 [TBL] [Abstract][Full Text] [Related]
20. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]